Crossmark

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation

Crossref DOI link: https://doi.org/10.1038/S41467-018-03640-Y

Published Online: 2018-04-10

Published Print: 2018-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Mukaro, Violet R.

Quach, Alex

Gahan, Michelle E.

Boog, Bernadette

Huang, Zhi H.

Gao, Xiuhui

Haddad, Carol

Mahalingam, Suresh http://orcid.org/0000-0003-3141-8410
Hii, Charles S.

Ferrante, Antonio
License Information

Text and Data Mining valid from 2018-04-10
More Information

Article History

Received: 21 November 2013

Accepted: 1 March 2018

First Online: 10 April 2018

Competing interests

: The technology has now been licensed to a commercial company (Niwalen Limited) by our institution. V.R.M., C.S.H. and A.F. may benefit financially under the awards and policy of the South Australian Government. The remaining authors declare no competing interests.